Breaking News: Institute of Biomedical Research Corp Acquires Biomedical and Nutraceutical Assets!
Institute of Biomedical Research Corp Announces Purchase of Biomedical and Nutraceutical Assets SEATTLE, WA, July 22, 2022 (GLOBE NEWSWIRE) — Institute of Biomedical Research Corp. (OTC Pink: MRES), a diversified biomedical company, announces the purchase of biomedical and nutraceutical assets from Wuhan General Group (China), Inc in an all-cash transaction (“Purchase”). This purchase is a…